Analyzing aggregate anonymous patient data over time enables pharmaceutical companies to better understand treatment efficacy and discover new market segments for generating revenue. Anonymized patient-level data (APLD), a longitudinally-linked record of patients’ medical and pharmaceutical care, provides detailed information on patient, payor, and provider dynamics — giving pharma a precise view of the interactions between/among these groups.
MSA’s patient matching technologies link de-identified disease-, diagnosis-, and treatment-centric information from different systems with varying formats – including separate clinical, laboratory, pharmacy, and claim systems – to maximize the pharma industry’s understanding of the patient journey and patient behavior, as well as the physician prescribing behavior.
Learn how MSA’s HIPAA-compliant/HITRUST-certified, state-of-the-art technologies help pharma use anonymized patient level data to drive their marketing, sales and overall strategies, ensuring the delivery of the right therapy to the right people, faster.
Download the Whitepaper Now